Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Our study aimed to identify the association of norepinephrine transporter gene (SLC6A2), synaptosomal-associated protein of the 25-kDa gene (SNAP-25), and latrophilin 3 gene (LPHN3) with osmotic-controlled release oral delivery system methylphenidate (OROS MPH) treatment response. METHODS: One hundred thirty-nine children and adolescents with attention-deficit/hyperactivity disorder (ADHD) were recruited. We selected rs192303, rs3785143 in SLC6A2; rs3746544 (1065 T>G) in SNAP-25; and rs6551665, rs1947274, and rs2345039 in LPHN3 to examine the association of OROS MPH treatment response with each single nucleotide polymorphism. We first defined good response group when the Korean version of the ADHD rating scale score at 8 weeks was decreased for more than 50% of baseline scores and compared genotype frequencies in good response group with poor group. Second, we defined it when the Clinical Global Impression-Improvement score at 8 weeks was 1 or 2, and we also analyzed the genotype frequencies. RESULTS: There was a significant association between the 1065 T>G of SNAP-25 gene and OROS MPH response, with the good response group defined by the Korean version of ADHD rating scale scores; 33.3% of the subjects with GG genotype showed a good response, whereas 74.7% of those with TT genotype and 72.5% of those with TG genotype showed good responses (P=0.034). SLC6A2 rs192303 was related with OROS MPH treatment response when we defined good treatment response by Clinical Global Impression-Improvement (P=0.009). CONCLUSIONS: Our study suggested that SNAP-25 gene and SLC6A2 were involved with OROS MPH response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020
Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., Atkins, M., McBurnett, K., Bukstein, O., August, G., et al. (2001) · Pediatrics · doi:10.1542/peds.108.4.883 · Cited by 502
Molecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411 · cited 1×
“The heritability of ADHD was estimated to be approximately 76% in 20 twin studies.(9) These findings support genetic etiology in ADHD.”
BackgroundPelham, W. E., Gnagy, E. M., Burrows-Maclean, L., Williams, A., Fabiano, G. A., Morrisey, S. M., Chronis, A. M., Forehand, G. L., Nguyen, C. A., Hoffman, M. T., et al. (2001) · Pediatrics · doi:10.1542/peds.107.6.e105 · Cited by 378
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers
GREENHILL, L. L., ABIKOFF, H. B., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., ELLIOTT, G., HECHTMAN, L., HINSHAW, S. P., HOZA, B., JENSEN, P. S., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199610000-00017 · Cited by 297
Adoptive and Biological Families of Children and Adolescents With ADHD
SPRICH, S., BIEDERMAN, J., CRAWFORD, M. H., MUNDY, E., & FARAONE, S. V. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200011000-00018 · Cited by 291 · cited 1×
“It has been found that 20% to 30% of parents or siblings of proband have the same disease,(6,7) and biological relatives show a higher rate of ADHD than adoptive relatives.(8) The heritability of ADHD was estimated to be approximately 76% in 20 twin studies.”
BackgroundBr�ss, M., Kunz, J., Lingen, B., & B�nisch, H. (1993) · Human Genetics · doi:10.1007/bf00218272 · Cited by 127 · cited 1×
“2, and about 300 single nucleotide polymorphisms (SNPs) were investigated.(16) It was reported that rs3785157, rs998424, rs3785143, rs11568324, and −3081(A/T) in SLC6A2 were associated with ADHD.”
BackgroundPharmacogenetics of Methylphenidate Response in Preschoolers With ADHD
McGOUGH, J., McCRACKEN, J., SWANSON, J., RIDDLE, M., KOLLINS, S., GREENHILL, L., ABIKOFF, H., DAVIES, M., CHUANG, S., WIGAL, T., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235083.40285.08 · Cited by 126 · cited 1×
“In preschoolers with ADHD, subjects with 1065 T>G T homozygous showed a medium positive effect on methylphenidate treatment, whereas 1069 T>C T homozygous showed a negative effect.(35) This finding was not replicated in a subsequent study that examined the role of candidate genes for methylphenidate response in ADHD a…”
ResultMick, E., Neale, B., Middleton, F. A., McGough, J. J., & Faraone, S. V. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30865 · Cited by 108
Cited by
Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD
Myer, N. M., Boland, J. R., & Faraone, S. V. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.234 · Cited by 91
SNAP-25 in Major Psychiatric Disorders: A Review.
Najera, K., Fagan, B. M., & Thompson, P. M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.02.008 · Cited by 43
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26
“Pharmacogenetic studies in humans have reported that genetic variants of the GRIN2B gene, encoding for an NMDA subunit, and the SNAP-25 gene , linked to NMDA receptor trafficking, were associated with better response to MPH in children (Kim et al., 2017, Song et al., 2014).”
BackgroundElsayed, N. A., Yamamoto, K. M., & Froehlich, T. E. (2020) · CNS Drugs · doi:10.1007/s40263-020-00702-y · Cited by 23
Yuan, D., Zhang, M., Huang, Y., Wang, X., Jiao, J., & Huang, Y. (2021) · Medicine · doi:10.1097/md.0000000000027858 · Cited by 21
Metadata
- Authors
- Song, J., Kim, S. W., Hong, H. J., Lee, M. G., Lee, B. W., Choi, T. K., Lee, S.-H., & Yook, K.-H.
- Venue
- Clinical Neuropharmacology
- Published
- 2014-09
- Volume
- 37
- Issue
- 5
- Pages
- 136-141
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W2075667707
- Cited by
- 24
- References
- 9
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder. https://app.cochat.ai/papers/10.1097/wnf.0000000000000045
- The paper
- Song, J., Kim, S. W., Hong, H. J., Lee, M. G., Lee, B. W., Choi, T. K., Lee, S.-H., & Yook, K.-H. (2014). Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000045
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.